The Role of L-2-Aminobutanamide HCl in Antiepileptic Drug Synthesis
In the intricate world of pharmaceutical manufacturing, specific chemical intermediates play pivotal roles in the creation of life-saving medications. L-2-Aminobutanamide Hydrochloride (CAS 7682-20-4) is one such compound, indispensable in the synthesis pathway of Levetiracetam, a cornerstone antiepileptic drug. This article sheds light on its chemical properties, its significance in drug synthesis, and the considerations for sourcing this vital material.
Chemical Profile and Importance
L-2-Aminobutanamide Hydrochloride, often referred to by its CAS number 7682-20-4, is a chiral organic compound. Its structure features an amino group and an amide group attached to a four-carbon chain, with the hydrochloride salt enhancing its solubility and handling properties. As a white crystalline powder, it meets specific quality parameters essential for pharmaceutical applications, including a high assay value (typically ≥99.0%) and minimal impurities. The enantiomeric purity, specifically the low content of the R-isomer, is critical because the biological activity of Levetiracetam is highly dependent on its specific stereochemistry.
The synthesis of Levetiracetam involves several chemical steps, and L-2-Aminobutanamide Hydrochloride serves as a key building block. Its accurate molecular structure and purity directly influence the yield and quality of the final Active Pharmaceutical Ingredient (API). Therefore, pharmaceutical companies must partner with reliable manufacturers who can consistently deliver this intermediate according to exact specifications. This ensures the efficacy and safety of the final drug product used by patients suffering from epilepsy.
Sourcing Strategies for R&D and Production
For researchers and production managers, securing a stable supply of L-2-Aminobutanamide Hydrochloride is a strategic imperative. When looking to purchase this compound, consider the following:
- Supplier Reputation: Engage with manufacturers known for their expertise in chiral chemistry and pharmaceutical intermediates. Look for companies with robust quality control systems and a proven track record.
- Specification Adherence: Verify that the supplier’s product meets all required specifications, including purity assays, impurity limits (e.g., R-isomer content), and physical properties.
- Scalability: Ensure the manufacturer can scale production to meet demand, from R&D quantities to commercial batch sizes.
- Technical Documentation: Access to comprehensive technical data, including CoAs, safety data sheets (SDS), and potentially process information, is vital for integration into your synthesis workflow.
- Commercial Terms: Discuss pricing, lead times, packaging options (e.g., 25kg drums), and delivery logistics to ensure a smooth procurement process.
As a crucial component in the production of a significant therapeutic agent, L-2-Aminobutanamide Hydrochloride demands meticulous sourcing. By understanding its chemical role and partnering with dependable suppliers, pharmaceutical firms can maintain high standards in their manufacturing operations, ultimately contributing to better patient outcomes.
Perspectives & Insights
Quantum Pioneer 24
“The enantiomeric purity, specifically the low content of the R-isomer, is critical because the biological activity of Levetiracetam is highly dependent on its specific stereochemistry.”
Bio Explorer X
“The synthesis of Levetiracetam involves several chemical steps, and L-2-Aminobutanamide Hydrochloride serves as a key building block.”
Nano Catalyst AI
“Its accurate molecular structure and purity directly influence the yield and quality of the final Active Pharmaceutical Ingredient (API).”